Skip to main content

Want a detailed portfolio tracker?

Envista (NVST) Free Cash Flow (2018 - 2026)

Envista (NVST) free cash flow from Sep 28, 2018 to Apr 3, 2026. The TTM Envista (NVST) free cash flow is $220M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Free Cash Flow

Quarterly Free Cash Flow

Envista (NVST) Free Cash Flow CAGR table

PeriodCAGR
1 Year TTM-17.77%
3 Years TTM+26.45%
5 Years TTM-7.23%
All Time TTM+9.22%

Annual Free Cash Flow change of Envista (NVST)

YearFree Cash FlowChange
2026-$16M-106.86%
2025$230M-23.89%
2024$303M+39.17%
2023$218M+103.27%
2022$107M-65.14%
2021$307M+29.93%
2020$236M-26.12%
2019$320M-2.50%
2018$328M+5.71%
2017$310MN/A

Comparison Envista (NVST) five years free cash flow CAGR with competitors

Envista (NVST) five years free cash flow CAGR is -7.23%.

TickerNamefive years Free Cash Flow CAGRUpside
STXSStereotaxis Inc56.19%-877.57%
NYXHNyxoah SA39.79%-650.58%
ALCAlcon Inc36.17%-600.56%
MBOTMicrobot Medical Inc35.61%-592.84%
GCTKGlucoTrack Inc33.97%-570.05%
ZTEKZentek Ltd32.49%-549.67%
COOCooper Companies Inc18.83%-360.60%
POCIPrecision Optics Corp Inc18.77%-359.70%
RMDResmed Inc18.60%-357.35%
RGENRepligen Corp18.20%-351.89%
LMATLemaitre Vascular Inc17.08%-336.36%
ISRGIntuitive Surgical Inc15.86%-319.52%
BLFSBiolife Solutions Inc14.23%-296.91%
MMSIMerit Medical Systems Inc10.60%-246.69%
WSTWest Pharmaceutical Services Inc8.32%-215.16%
PLSEPulse Biosciences Inc8.01%-210.87%
EKSOEkso Bionics Holdings Inc6.09%-184.21%
OSUROrasure Technologies Inc5.74%-179.37%
ATRAptargroup Inc1.13%-115.67%